SBFM SUNSHINE BIOPHARMA INC Investments/Divestments 8-K Filing 2023 - Termination of Research Agreement Sunshine Biopharma terminates research agreement with Jewish General Hospital for anti-cancer drug Adva-27a due to unfavorable lab results.Get access to all SEC 8-K filings of the SUNSHINE BIOPHARMA INC